Association of genetic variants in CYP3A4, CYP3A5, CYP2C8, and CYP2C19 with tacrolimus pharmacokinetics in renal transplant recipients

Z Wang, M Zheng, H Yang, Z Han, J Tao… - Current Drug …, 2019 - ingentaconnect.com
Background: Our study aimed to investigate the pharmacogenetics of cytochrome P3A4
(CYP3A4), CYP3A5, CYP2C8, and CYP2C19 and their influence on TAC Pharmacokinetics …
被引用次数：10 相关文章

Association of Genetic Variants in CYP3A4, CYP3A5, CYP2C8, and CYP2C19 with Tacrolimus Pharmacokinetics in Renal Transplant Recipients.

Z Wang, M Zheng, H Yang, Z Han, J Tao… - Current Drug …, 2019 - europepmc.org
BACKGROUND: Our study aimed to investigate the pharmacogenetics of cytochrome P3A4
(CYP3A4), CYP3A5, CYP2C8, and CYP2C19 and their influence on TAC Pharmacokinetics …

Association of Genetic Variants in CYP3A4, CYP3A5, CYP2C8, and CYP2C19 with Tacrolimus Pharmacokinetics in Renal Transplant Recipients

Z Wang, M Zheng, H Yang, Z Han… - Current drug …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Our study aimed to investigate the pharmacogenetics of cytochrome P3A4
(CYP3A4), CYP3A5, CYP2C8, and CYP2C19 and their influence on TAC Pharmacokinetics …